MAPK1 and hepatocellular carcinoma: Moreover, human HCC samples displaying high MAPK/ERK or MYC pathway activation were over-represented in patients exhibiting a stronger enrichment of the prognostic myeloid signature Myeloid Response Score (MRS, Supplementary Fig. 3g), which correlates with immunosuppressive and pro-tumorigenic TME features69.